The drug-drug interactions associated with kinase inhibitor treatment are addressed on this online resource. This section, ‘Prophylaxis and treatment’, comprises the following sub-sections:
- What healthcare professionals (HCPs) should know: the key treatment principles for kinase inhibitor-related drug-drug interactions.
- What patients can do: the key behavioural and prophylactic measures that can be undertaken by patients to minimise drug-drug interaction side effects.
- Prophylactic management: therapeutic principles which help to minimise drug-drug interaction-related toxicities.
- Reactive management: general information on close monitoring of and early intervention in drug-drug interactions associated with kinase inhibitors.